Skinbiotherapeutics Share Discussion Threads

[shrewdmole] 08/8/2020 21:53

Nik

To be fair SA mentions in the interview those figures. And when he was appointed the company said it was to build a £500m business.

Admittedly that’s a few years off, but so far so good, SA has got every step right so far in particular in my view appointing cenkos.

S

[nik7907] 08/8/2020 21:30

Just to add my largest holding

[m4rtinu] 08/8/2020 21:28

Stating the obvious, probably need to set up a separate entity for each strain. Like OPTI and Probiotix. So that the likes of Croda could buy that part of SBTX that is relevant to them. And we can maximise value. But as said, not yet as too cheap.

[nik7907] 08/8/2020 21:28

It's a compelling company that's for sure. I have been pulled into a few in the past and regretted it. I believe this is a good bet but please don't encourage people with 2/3 4 pound targets. May get there but seen others fail massively in the past

[lovewinshatelosses] 08/8/2020 20:50

This is one reason why a FTSE listing in this case - if we don't get taken out - really appeals to me. We can all think of names that still went bust on the FTSE markets, but the number of really successful AIM companies, over a sustained period of time, is really small. Of no consequence to traders, but maybe different for LTHs. Anyway, let's start generating income first...

[shrewdmole] 08/8/2020 20:33

It’s funny as more people look at this company and the research they buy. Several of my contacts have and are still adding along the way.

It’s hard to see how big this can be.

[gary hindsight] 08/8/2020 19:26

Yes it was his comment when discussing why he hadn't bought shares due to inside info nearly all the time and he said no one will complain if the share price is £3-4. It was that comment that triggered my post on doing some basic maths on % conversion of sederma clients. You can easily get close to that type of price on this product aloneAs I said before just 10% conversion gives at least 2.5m rev to sbtx. P/E of 10 gets to current market cap given such low cost base100% conversion / matrixyl replacement gets you to a P/E of 1.

[lovewinshatelosses] 08/8/2020 19:09

That sounds delightful and what a pleasant headache, as I did originally plan to top slice at 30p. I think I might sit back and wait for Stuart to (hopefully) reach his fist target of 40p and then review. I have recommended a close friend take a look at this company, just before the recent rise in fact. If he decides to take a position, it will probably knock spots off my total holding here - but not certifiable level. Like me though, he would probably look to hold most of his stock for the long game. Anyway, thanks for your thoughts and enjoy the rest of the weekend.

[shrewdmole] 08/8/2020 18:45

Love wins

I can see a strain being taken out possibly croda and skinbiotix. That would give cath serious firepower to progress all the other stuff.

Another SA comment the pipeline is FULL.

[lovewinshatelosses] 08/8/2020 18:27

Shrewdmole and others - if we were taken out, would not those other less developed strands of IP that Cath has also been working on, fall under the same company ownership? Not looking to get too far ahead here, just curious. I guess they could potentially be negotiated out of any t/o deal, in answer to my own question. I am also pondering a small top up next week too - Fridays close felt strong.

[shrewdmole] 08/8/2020 15:33

Only just had a chance to listen properly to elrico interview with SA.

All I can say is WOW. Even I’m blown away by his comments.

6 globals now talking cleanbiotix.
£2/3/4 share price he really believes in this.

One thing I keep saying and he keeps suggesting smith and nephew will throw some funding at cath I reckon as apart of a deal.

Psoriasis alone could be multi million revenues. I see that working like seed does subscription and worldwide shipping from an online portal.

All really exciting.

May have to have a wee top up Monday.

[slartybartfaster] 08/8/2020 10:50

I thought Elrics latest interview with SA on Monday is the the most revealing of them all. He teased out a clear timine for product role out for both croda and winclove.

[lovewinshatelosses] 07/8/2020 13:36

Well, private equity, Croda or even the grand old duke of York, can have mine right now for a quid a pop - but maybe not if we are allowed to develop substantially further. I might want more then, but OPTI and the other big holders are all that matters on such a front - if indeed that day does ever come.

[gary hindsight] 07/8/2020 13:24

Quite possible as it makes long term financial sense for croda to keep the royalty element in house

[shrewdmole] 07/8/2020 13:04

Gary

I still believe croda will take out skinbiotix. For them to pay 7 x earnings so £140m in the long run is cheap.

If I were SA I’d take that give shareholders a special divi and fast track caths hoard of strains she has!

S

[gary hindsight] 07/8/2020 11:58

Ok so a takeover as opposed to taking it private by just delisting as that is a lobster pot

[madaboutmed] 07/8/2020 11:16

Sincerely hope so.

[pj 1] 07/8/2020 11:10

A few years ago I recall an article which reviewed the number of listed take overs I think it was in 2017 perhaps 2018.

The figures suggested Private Equity paid 30% more than another listing Company taking control, and buying the full share capital. (estimated against the 30 day share price average share price before announcement.)

[gary hindsight] 07/8/2020 10:51

Agree moving to main list doesn't add much in the near term they are more a less 3 people full time I think. IHT and stamp duty a benefit of aim. There are large companies on aim which investment companies invest in its about market capHowever I don't understand why you say to take it private? How would I realise value if I can't sell them without trying to find a private buyer?

[parob] 07/8/2020 10:45

Are we going to start climbing again soon?

[lovewinshatelosses] 06/8/2020 21:17

Er, for a start, because few funds will touch AIM stocks and sticky large holders are great for underpinning a share price; plenty of other reasons too - although AIM has its uses, especially for trading e.g. tax differences etc. This was not a bizarre comment and it is very premature to suggest we will never have funding requirements ever again. Just take a glance at several FTSE100 companies in fairly recent history - let alone AIM - as proof therein. That's not to suggest said large corporates will not repay holders well in the coming years.

[pj 1] 06/8/2020 20:50

If the are successful on AIM why would they move listing with no funding requirements?? Surely investors would want it taking private?

Truly bizarre comments on here and OPTI recently

[lovewinshatelosses] 06/8/2020 20:38

Thanks jansky - definitely looking far into the future and not an attempt to ramp etc. I do think that if things progress as we hope, it should become a serious consideration. For all the regulatory and financial burden versus AIM, I think it's probably worth the hassle, if the long term aspirations and commercial capabilities are serious. Anyway, plenty more to go before that even becomes something to seriously consider.

[jansky61] 06/8/2020 19:38

I've lost track a bit since I retired so can't give you any figures but the AIM listing rules are a lot less onerous than those required by the main market and the annual listing fees reflect that. SBTX market cap is currently around £32m which is tiny compared to most companies with a full listing so IMO I wouldn't have thought it's on their priority list yet although I'm sure they will consider it at a future date as the Company progresses. Of 130m shares in issue only 40% are in private hands which could be another deciding factor.

I remember flicking through this occasionally, you will see how low SBTX would be on the list!!